HLA-haploidentical allografting with high-dose post-transplant cyclophosphamide: clinical outcomes and immunereconstitution.
Busca Alessandro, Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Enrico Maffini(Istituto di Ematologia di Bologna), Chiara Dellacasa, Elona Saraci(University of Turin), Roberta Pulito, Paola Omedè(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Boccadoro Mario, Federica Ferrando
Institutional Research Information System University of Turin (University of Turin)
January 1, 2015
Cited by 0
Related Papers
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
|Blood|2003|407
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
|Blood|2023|330